Veru Yönetim

Yönetim kriter kontrolleri 3/4

Veru CEO'su Mitch Steiner, Oct2016 tarihinde atandı, in görev süresi 8.08 yıldır. in toplam yıllık tazminatı $ 4.71M olup, şirket hissesi ve opsiyonları dahil olmak üzere 18.4% maaş ve 81.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 4.84% ine doğrudan sahiptir ve bu hisseler $ 5.20M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.2 yıl ve 3.9 yıldır.

Anahtar bilgiler

Mitch Steiner

İcra Kurulu Başkanı

US$4.7m

Toplam tazminat

CEO maaş yüzdesi18.4%
CEO görev süresi8.1yrs
CEO sahipliği4.8%
Yönetim ortalama görev süresi6.2yrs
Yönetim Kurulu ortalama görev süresi3.9yrs

Son yönetim güncellemeleri

Recent updates

Is Veru (NASDAQ:VERU) A Risky Investment?

Aug 07
Is Veru (NASDAQ:VERU) A Risky Investment?

What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You

Jul 17
What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You

Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

May 31
Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Jan 09
The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Aug 16
Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Apr 17
Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Feb 14
Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Jan 13
Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Nov 13
Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Veru Inc.: Safer Bet Is To Wait For The AdComm Verdict

Oct 17

Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Sep 26
Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Veru FDA AdCom meeting for COVID-19 therapy postponed

Sep 19

Veru: A Good Combination Of A Stable Business And Growth Opportunities

Sep 13

Veru surges 11% as FDA sets AdCom meeting to review COVID-19 therapy

Sep 07

Veru sheds 13% to end rally as director sells shares

Aug 18

Veru Q3 2022 Earnings Preview

Aug 10

Veru updated analysis on COVID treatment sabizabulin will lead to EUA - Oppenheimer

Aug 03

Veru eligible for expedited review in U.K. for COVID-19 therapy

Jul 25

CEO Tazminat Analizi

Mitch Steiner'un ücretlendirmesi Veru'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$37m

Mar 31 2024n/an/a

-US$39m

Dec 31 2023n/an/a

-US$63m

Sep 30 2023US$5mUS$866k

-US$93m

Jun 30 2023n/an/a

-US$126m

Mar 31 2023n/an/a

-US$136m

Dec 31 2022n/an/a

-US$116m

Sep 30 2022US$6mUS$761k

-US$84m

Jun 30 2022n/an/a

-US$47m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021n/an/a

-US$16m

Sep 30 2021US$2mUS$618k

US$7m

Jun 30 2021n/an/a

-US$144k

Mar 31 2021n/an/a

-US$476k

Dec 31 2020n/an/a

US$2m

Sep 30 2020US$1mUS$502k

-US$19m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$10m

Dec 31 2019n/an/a

-US$13m

Sep 30 2019US$800kUS$392k

-US$12m

Jun 30 2019n/an/a

-US$17m

Mar 31 2019n/an/a

-US$22m

Dec 31 2018n/an/a

-US$22m

Sep 30 2018US$740kUS$383k

-US$24m

Tazminat ve Piyasa: Mitch 'nin toplam tazminatı ($USD 4.71M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 653.78K ).

Tazminat ve Kazançlar: Mitch 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Mitch Steiner (63 yo)

8.1yrs

Görev süresi

US$4,714,041

Tazminat

Dr. Mitchell S. Steiner, also known as Mitch, M.D., F.A.C.S, has been the Chief Executive Officer, President and Director at Veru Inc. (formerly known as The Female Health Company) since October 31, 2016 &...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Mitchell Steiner
Chairman8.1yrsUS$4.71m4.84%
$ 5.2m
Harry Fisch
Vice Chairman & Chief Corporate Officer8.1yrsVeri yok5.47%
$ 5.9m
Michele Greco
CFO & Chief Administrative Officer6.9yrsUS$1.55m0.066%
$ 70.6k
K. Barnette
Chief Scientific Officer6.2yrsUS$1.69m0.0034%
$ 3.7k
Samuel Fisch
Executive Director of Investor Relations & Corporate Communications5.6yrsVeri yokVeri yok
Michael Purvis
Executive VP3.7yrsVeri yokVeri yok
Kevin Gilbert
Executive Vice President of Corporate Development7.8yrsVeri yokVeri yok
Martin Tayler
Executive Vice President of FC2 Global Operationsno dataUS$193.01kVeri yok
Philip Greenberg
Executive VP & Deputy General Counsel3.8yrsVeri yokVeri yok
Domingo Rodriguez
Executive Vice President of Global Clinical Operations6.6yrsVeri yokVeri yok
Gary Bird
Executive Vice President of Quality & Regulatory Affairs5.8yrsVeri yokVeri yok
Jason Davies
Executive VP and GM of UK2.3yrsVeri yokVeri yok

6.2yrs

Ortalama Görev Süresi

62.5yo

Ortalama Yaş

Deneyimli Yönetim: VERU 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.2 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Mitchell Steiner
Chairman8.1yrsUS$4.71m4.84%
$ 5.2m
Harry Fisch
Vice Chairman & Chief Corporate Officer8.1yrsVeri yok5.47%
$ 5.9m
Louis Aronne
Chief Medical Advisor & Member of the Scientific Advisoryless than a yearVeri yokVeri yok
David D. Ho
Chairman of Scientific Advisory Board1.8yrsVeri yokVeri yok
Andrew Love
Board Observer8.1yrsVeri yokVeri yok
Robert Schooley
Member of the Scientific Advisory Board1.4yrsVeri yokVeri yok
Michael Rankowitz
Independent Director6.7yrsUS$875.93k0.068%
$ 73.4k
Xiaoqin Lu
Independent Director3.5yrsUS$835.75k0.0067%
$ 7.2k
Caroline Apovian
Member of Scientific Advisory Boardless than a yearVeri yokVeri yok
Mario Eisenberger
Independent Director8.1yrsUS$795.57k0%
$ 0
Grace Hyun
Independent Director4.3yrsUS$755.39k0.010%
$ 10.8k
Erik Swenson
Member of the Scientific Advisory Board1.4yrsVeri yokVeri yok

3.9yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: VERU 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).